Fig. 2

Amifostine attenuates bleomycin-induced pulmonary immunological responses. Lung injury and immunological responses were assessed by the analysis of BAL samples collected on day 7 and day 21. a, c, d Neutrophils, macrophages and lymphocytes were quantified. b BAL protein was also measured. e–i Proinflammatory and profibrotic cytokines were analyzed. n = 10, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001